{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:01:18Z","timestamp":1791104478293,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.ygyno.2006.08.052","type":"journal-article","created":{"date-parts":[[2006,10,25]],"date-time":"2006-10-25T11:29:34Z","timestamp":1161775774000},"page":"331-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":170,"title":["Emerging roles for PAX8 in ovarian cancer and endosalpingeal development"],"prefix":"10.1016","volume":"104","author":[{"given":"Nathan J.","family":"Bowen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Logani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin B.","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura B.","family":"Kapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict B.","family":"Benigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2006.08.052_bib1","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ygyno.2006.08.052_bib2","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1091\/mbc.e03-05-0279","article-title":"Gene expression patterns in ovarian carcinomas","volume":"14","author":"Schaner","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ygyno.2006.08.052_bib3","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1073\/pnas.98.3.1176","article-title":"Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer","volume":"98","author":"Welsh","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2006.08.052_bib4","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0002-9440(10)63605-X","article-title":"Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma","volume":"163","author":"Tsuchiya","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2006.08.052_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-4598-3-27","article-title":"Gene expression profiling of epithelial ovarian tumours correlated with malignant potential","volume":"3","author":"Warrenfeltz","year":"2004","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ygyno.2006.08.052_bib6","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.bjc.6601603","article-title":"Predicting biomarkers for ovarian cancer using gene-expression microarrays","volume":"90","author":"Adib","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2006.08.052_bib7","first-page":"3466","article-title":"Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays","volume":"62","author":"Bayani","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2006.08.052_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/gcc.10084","article-title":"Transcriptional profiling reveals that several common fragile-site genes are downregulated in ovarian cancer","volume":"34","author":"Denison","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ygyno.2006.08.052_bib9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ygyno.2004.11.039","article-title":"Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling","volume":"96","author":"Gilks","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.08.052_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9440(10)63306-8","article-title":"Differential gene expression in ovarian carcinoma: identification of potential biomarkers","volume":"165","author":"Hibbs","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2006.08.052_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mc.10098","article-title":"Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma","volume":"36","author":"Jazaeri","year":"2003","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ygyno.2006.08.052_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsgi.2003.07.004","article-title":"Gene expression patterns that characterize advanced stage serous ovarian cancers","volume":"11","author":"Lancaster","year":"2004","journal-title":"J. Soc. Gynecol. Investig."},{"key":"10.1016\/j.ygyno.2006.08.052_bib13","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1158\/1078-0432.CCR-03-0409","article-title":"Jr., Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis","volume":"10","author":"Lu","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2006.08.052_bib14","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","article-title":"Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon","volume":"11","author":"Marquez","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2006.08.052_bib15","first-page":"5007","article-title":"Identification by cDNA microarray of genes involved in ovarian carcinogenesis","volume":"60","author":"Ono","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2006.08.052_bib16","first-page":"4722","article-title":"Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas","volume":"62","author":"Schwartz","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2006.08.052_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0090-8258(03)00257-9","article-title":"Overexpression of kallikrein 10 in epithelial ovarian carcinomas","volume":"90","author":"Shvartsman","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.08.052_bib18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/cyto.10042","article-title":"Transcriptional profiling develops molecular signatures for ovarian tumors","volume":"47","author":"Smith","year":"2002","journal-title":"Cytometry"},{"key":"10.1016\/j.ygyno.2006.08.052_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-1119(99)00035-9","article-title":"Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray","volume":"229","author":"Wang","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.ygyno.2006.08.052_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0168-9525(01)02594-X","article-title":"Getting your Pax straight: Pax proteins in development and disease","volume":"18","author":"Chi","year":"2002","journal-title":"Trends Genet."},{"key":"10.1016\/j.ygyno.2006.08.052_bib21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1242\/dev.116.3.611","article-title":"PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors","volume":"116","author":"Poleev","year":"1992","journal-title":"Development"},{"key":"10.1016\/j.ygyno.2006.08.052_bib22","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1432-1033.1995.tb20338.x","article-title":"Distinct functional properties of three human paired-box-protein, PAX8, isoforms generated by alternative splicing in thyroid, kidney and Wilms' tumors","volume":"228","author":"Poleev","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ygyno.2006.08.052_bib23","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1038\/sj.onc.1206766","article-title":"Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival","volume":"22","author":"Muratovska","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2006.08.052_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng0598-83","article-title":"PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis","volume":"19","author":"Macchia","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ygyno.2006.08.052_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ng0598-87","article-title":"Follicular cells of the thyroid gland require Pax8 gene function","volume":"19","author":"Mansouri","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ygyno.2006.08.052_bib26","series-title":"Robbins pathologic basis of disease","author":"Cotran","year":"1994"},{"key":"10.1016\/j.ygyno.2006.08.052_bib27","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.289.5483.1357","article-title":"PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma","volume":"289","author":"Kroll","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2006.08.052_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/1097-0142(19890115)63:2<280::AID-CNCR2820630213>3.0.CO;2-N","article-title":"Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors","volume":"63","author":"Geisinger","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2006.08.052_bib29","first-page":"5379","article-title":"Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors","volume":"43","author":"Hamilton","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2006.08.052_bib30","series-title":"Endless forms most beautiful: the new science of evo devo","author":"Carroll","year":"2005"},{"key":"10.1016\/j.ygyno.2006.08.052_bib31","series-title":"Developmental biology","author":"Gilbert","year":"2000"},{"key":"10.1016\/j.ygyno.2006.08.052_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/17068","article-title":"Female development in mammals is regulated by Wnt-4 signalling","volume":"397","author":"Vainio","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2006.08.052_bib33","series-title":"Cancer medicine","author":"Kufe","year":"2005"},{"key":"10.1016\/j.ygyno.2006.08.052_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1051\/rnd:2005020","article-title":"The fallopian tubes in domestic mammals: how vital is their physiological activity?","volume":"45","author":"Hunter","year":"2005","journal-title":"Reprod. Nutr. Dev."},{"key":"10.1016\/j.ygyno.2006.08.052_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/aja.1001870109","article-title":"Oviductal epithelium of the baboon: hormonal control and the immuno-gold localization of oviduct-specific glycoproteins","volume":"187","author":"Verhage","year":"1990","journal-title":"Am. J. Anat."},{"key":"10.1016\/j.ygyno.2006.08.052_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/aja.1001690107","article-title":"Effects of progesterone on the oviductal epithelium in estrogen-primed prepubertal beagles: light and electron microscopic observations","volume":"169","author":"Sawyer","year":"1984","journal-title":"Am. J. Anat."},{"key":"10.1016\/j.ygyno.2006.08.052_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/aja.1001620203","article-title":"Control of the secretory cell cycle in cat oviduct by estradiol and progesterone","volume":"162","author":"Bareither","year":"1981","journal-title":"Am. J. Anat."},{"key":"10.1016\/j.ygyno.2006.08.052_bib38","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1002\/j.1460-2075.1995.tb00251.x","article-title":"Loss of p53 function through PAX-mediated transcriptional repression","volume":"14","author":"Stuart","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.ygyno.2006.08.052_bib39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(95)90412-3","article-title":"Tumor suppressor p53 is a direct transcriptional activator of the human bax gene","volume":"80","author":"Miyashita","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2006.08.052_bib40","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/emboj\/17.8.2319","article-title":"Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments","volume":"17","author":"Nutt","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.ygyno.2006.08.052_bib41","first-page":"F73","article-title":"Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice","volume":"268","author":"Sorenson","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ygyno.2006.08.052_bib42","first-page":"3211","article-title":"Transcriptional activation of the bcl-2 apoptosis suppressor gene by the paired box transcription factor PAX8","volume":"17","author":"Hewitt","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2006.08.052_bib43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1365-2559.2001.1163c.x","article-title":"Cell cycle-related proteins p21 and bcl-2: markers of differentiation in the human fallopian tube","volume":"38","author":"Piek","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2006.08.052_bib44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.08.052_bib45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806006962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806006962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:21:41Z","timestamp":1758770501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825806006962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0090825806006962"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2006.08.052","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2006.08.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}